ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

FRANCISCO PLA MENDEZ

PMB 123 MAILBOX SET C 35 JUAN CARLOS DE BARBON SUITE 67

Guaynabo | Puerto Rico | 00969

(787) 510-1588

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 1479

$355K Total Retail Price of All Prescriptions

Rank: 118 out of 1479

495 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 9,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 330 330 1 1
DONEPEZIL HCL 316 306 2 45
AMLODIPINE BESYLATE 316 312 2 6
LEVOTHYROXINE SODIUM 290 290 4 9
FUROSEMIDE 283 282 5 15
GABAPENTIN 274 254 6 5
LOSARTAN POTASSIUM 242 233 7 8
SERTRALINE HCL 204 184 8 38
FAMOTIDINE 203 198 9 47
ENALAPRIL MALEATE 183 183 10 3
NAMENDA 181 181 11 69
METFORMIN HCL 179 170 12 2
SYNTHROID 171 162 13 12
OMEPRAZOLE 164 157 14 7
ATENOLOL 153 153 15 11
TRAZODONE HCL 148 148 16 122
METOPROLOL TARTRATE 137 134 17 17
CARVEDILOL 135 135 18 32
DIGOXIN 132 130 19 61
ISOSORBIDE MONONITRATE ER 129 126 20 31
CLOTRIMAZOLE-BETAMETHASONE 129 119 20 39
SILVER SULFADIAZINE 123 119 22 130
RANITIDINE HCL 120 108 23 4
MEGESTROL ACETATE 120 119 R 23 109
WARFARIN SODIUM 108 108 25 83
TAMSULOSIN HCL 107 107 26 36
QUETIAPINE FUMARATE 105 101 27 108
LISINOPRIL 97 97 28 16
PLAVIX 87 87 29 52
PANTOPRAZOLE SODIUM 83 74 30 48
AZITHROMYCIN 82 79 31 25
METOPROLOL SUCCINATE 82 82 31 51
SEROQUEL 79 79 33 203
GALANTAMINE HBR 78 78 34 220
TRAMADOL HCL-ACETAMINOPHEN 77 76 35 18
CIPROFLOXACIN HCL 73 70 36 26
RISPERIDONE 68 66 37 88
CLOPIDOGREL 67 61 38 46
GLIMEPIRIDE 66 61 39 21
PAROXETINE HCL 64 64 40 77
CITALOPRAM HBR 63 61 41 98
HYDROCHLOROTHIAZIDE 60 60 42 10
DIOVAN 60 60 42 85
LOSARTAN-HYDROCHLOROTHIAZIDE 59 48 44 14
MECLIZINE HCL 55 55 45 50
ZOLPIDEM TARTRATE 50 50 46 23
ATORVASTATIN CALCIUM 50 49 46 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.